Laddar...
Targeting metabotropic glutamate receptors for novel treatments of schizophrenia
Support for the N-methyl-d-aspartate receptor (NMDAR) hypofunction hypothesis of schizophrenia has led to increasing focus on restoring proper glutamatergic signaling as an approach for treatment of this devastating disease. The ability of metabotropic glutamate (mGlu) receptors to modulate glutamat...
Sparad:
| I publikationen: | Mol Brain |
|---|---|
| Huvudupphovsmän: | , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
BioMed Central
2017
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5405554/ https://ncbi.nlm.nih.gov/pubmed/28446243 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13041-017-0293-z |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|